These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2137131

  • 1. In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone.
    Goffinet AM, Leysen J, Labar D.
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):140-2. PubMed ID: 2137131
    [Abstract] [Full Text] [Related]

  • 2. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR, Satyamurthy N, Huang SC, Keen RE, Nissenson CH, Hoffman JM, Ackermann RF, Bahn MM, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [Abstract] [Full Text] [Related]

  • 3. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 4. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX, Hatada Y, Black LE, Creese I, Sibley DR.
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE, Janssen PM, Gommeren W, Wynants J, Pauwels PJ, Janssen PA.
    Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [Abstract] [Full Text] [Related]

  • 7. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH, Wienhard K, Stöcklin G, Laufer P, Hebold I, Pawlik G, Heiss WD.
    Eur J Nucl Med; 1988 Sep; 14(2):80-7. PubMed ID: 2968911
    [Abstract] [Full Text] [Related]

  • 8. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH, Jackson JR, Luedtke RR, Ivins KJ, Molinoff PB, Ehrenkaufer RL.
    J Med Chem; 1992 Feb 07; 35(3):423-30. PubMed ID: 1531364
    [Abstract] [Full Text] [Related]

  • 9. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA.
    J Med Chem; 1998 Dec 03; 41(25):5084-93. PubMed ID: 9836624
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR, Scheffel UA, Stathis M, Musachio JL, Wagner HN.
    Life Sci; 1990 Dec 03; 46(26):1967-76. PubMed ID: 2362552
    [Abstract] [Full Text] [Related]

  • 11. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK.
    J Pharmacol Exp Ther; 1992 Jun 03; 261(3):1282-90. PubMed ID: 1534844
    [Abstract] [Full Text] [Related]

  • 12. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
    Baldessarini RJ, Kula NS, Campbell A, Bakthavachalam V, Yuan J, Neumeyer JL.
    Mol Pharmacol; 1992 Nov 03; 42(5):856-63. PubMed ID: 1435753
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V.
    J Neural Transm Suppl; 1983 Nov 03; 18():165-79. PubMed ID: 6192208
    [Abstract] [Full Text] [Related]

  • 14. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC, Bahn MM, Barrio JR, Hoffman JM, Satyamurthy N, Hawkins RA, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec 03; 9(6):850-8. PubMed ID: 2531148
    [Abstract] [Full Text] [Related]

  • 15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 03; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 16. Characterization of (3H)-spiperone binding to alpha 1-adrenergic receptors in a smooth muscle cell line.
    Light KE, Cornett LE, Norris JS.
    J Recept Res; 1985 Nov 03; 5(5-6):335-48. PubMed ID: 3003352
    [Abstract] [Full Text] [Related]

  • 17. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep 03; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 18. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C, Fuchs S.
    Mol Pharmacol; 1991 Nov 03; 40(5):712-6. PubMed ID: 1834930
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T.
    J Pharmacol Exp Ther; 1993 Jan 03; 264(1):158-65. PubMed ID: 8093723
    [Abstract] [Full Text] [Related]

  • 20. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM, Huang SC, Hawkins RA, Satyamurthy N, Hoffman JM, Barrio JR, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec 03; 9(6):840-9. PubMed ID: 2531147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.